Clinical Trial Update: A Retrospective Observational Study of Nivolumab in Combination With Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC Patients: Real-World Experience in Taiwan (NEOREAL)

View source ↗

Summary

An observational real-world study from Taiwan is evaluating nivolumab in combination with chemotherapy as neoadjuvant therapy for resectable non-small cell lung…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Opdivo (nivolumab) (nivolumab)

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Non Small Cell Lung Cancer NSCLC | Status: NOT_YET_RECRUITING